MYELOID SARCOMA
Clinical trials for MYELOID SARCOMA explained in plain language.
Never miss a new study
Get alerted when new MYELOID SARCOMA trials appear
Sign up with your email to follow new studies for MYELOID SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to improve survival in aggressive leukemia
Disease control CompletedThis large phase III trial tested whether adding the drugs bortezomib and sorafenib to standard chemotherapy helps people with newly diagnosed acute myeloid leukemia (AML) live longer without the cancer returning. Over 1,600 participants took part. The study focused on patients w…
Matched conditions: MYELOID SARCOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Tailoring chemo by genetics and health may boost survival in older AML patients
Disease control CompletedThis study tested whether matching chemotherapy intensity to a patient's genetic risk and overall health could improve outcomes for older adults (60+) with acute myeloid leukemia. 75 participants received either standard intensive or lower-intensity chemo based on their individua…
Matched conditions: MYELOID SARCOMA
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC